1. Home
  2. FBLG vs HNNA Comparison

FBLG vs HNNA Comparison

Compare FBLG & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBLG
  • HNNA
  • Stock Information
  • Founded
  • FBLG 2021
  • HNNA 1989
  • Country
  • FBLG United States
  • HNNA United States
  • Employees
  • FBLG N/A
  • HNNA N/A
  • Industry
  • FBLG
  • HNNA Investment Managers
  • Sector
  • FBLG
  • HNNA Finance
  • Exchange
  • FBLG NYSE
  • HNNA Nasdaq
  • Market Cap
  • FBLG 91.0M
  • HNNA 73.8M
  • IPO Year
  • FBLG 2024
  • HNNA N/A
  • Fundamental
  • Price
  • FBLG $2.41
  • HNNA $10.49
  • Analyst Decision
  • FBLG Strong Buy
  • HNNA
  • Analyst Count
  • FBLG 3
  • HNNA 0
  • Target Price
  • FBLG $13.33
  • HNNA N/A
  • AVG Volume (30 Days)
  • FBLG 202.7K
  • HNNA 8.0K
  • Earning Date
  • FBLG 11-12-2024
  • HNNA 12-04-2024
  • Dividend Yield
  • FBLG N/A
  • HNNA 5.34%
  • EPS Growth
  • FBLG N/A
  • HNNA 25.53
  • EPS
  • FBLG N/A
  • HNNA 0.80
  • Revenue
  • FBLG N/A
  • HNNA $27,126,000.00
  • Revenue This Year
  • FBLG N/A
  • HNNA N/A
  • Revenue Next Year
  • FBLG N/A
  • HNNA N/A
  • P/E Ratio
  • FBLG N/A
  • HNNA $12.78
  • Revenue Growth
  • FBLG N/A
  • HNNA 11.90
  • 52 Week Low
  • FBLG $1.08
  • HNNA $6.36
  • 52 Week High
  • FBLG $46.00
  • HNNA $11.99
  • Technical
  • Relative Strength Index (RSI)
  • FBLG 39.00
  • HNNA 58.06
  • Support Level
  • FBLG $2.87
  • HNNA $10.04
  • Resistance Level
  • FBLG $2.72
  • HNNA $11.00
  • Average True Range (ATR)
  • FBLG 0.38
  • HNNA 0.42
  • MACD
  • FBLG -0.12
  • HNNA -0.00
  • Stochastic Oscillator
  • FBLG 14.94
  • HNNA 54.05

About FBLG FIBROBIOLOGICS INC

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced and fixed income products. It provides investment advisory services and shareholder services to the Hennessy Funds. Its investment advisory services include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities in accordance with the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.

Share on Social Networks: